Structural heart disease articles

Do NOACs Result in Any Benefit in TAVR?

Do NOACs Result in Any Benefit in TAVR?

Courtesy of Dr. Carlos Fava. The need for anticoagulation after transcatheter aortic valve replacement (TAVR) is over 15% according to different reports and, so far, no one has analyzed in depth whether new oral anticoagulant agents (non-vitamin K oral anticoagulants [NOACs]) result in superior benefit compared with classic vitamin K antagonists (VKAs). This study analyzed

El TAVI aún no es seguro en pacientes de bajo riesgo

FDA Expands TAVR Indication to Low-Risk Patients

Both the self-expandable valve Evolut R and its direct competitor, balloon-expandable valve Sapien 3, received the authorization to be indicated for low-risk patients in a long-awaited announcement made on August 16th, 2019. The US Food and Drug Administration (FDA) has approved and expanded the indication for the Evolut series (Medtronic) and the Sapien 3 and

Dr. José Mangione Inaugurated as New SOLACI President

Dr. José Mangione, renowned Latin American interventional cardiologist of ample trajectory, is now in charge of the Latin American Interventional Cardiology’s destiny for the next two years, following Dr. José Luis Leiva Pons’ (Mexico) successful administration. “I am honored and delighted to take this responsibility”, stated Dr. Mangione during the closing ceremony of SOLACI-SBHCI 2019.

El último día del Congreso llegó repleto de actividades de SOLACI

Last Congress Day Full of SOLACI Activities

The last day of the SOLACI-SBHCI 2019 Congress was full of sessions where different SOLACI areas were widely represented. The first morning session was “From SOLACI to SBHCI // México, Centro América and El Caribe Present: Más Allá de las Coronarias,” which addressed issues related to coronary angioplasty, the importance of imaging in structural procedures,

SOLACI Celebrated 25 Years during SOLACI-SBHCI 2019

During the opening ceremony of SOLACI-SBHCI 2019, the president of the Latin American Society of Interventional Cardiology, Dr. José Luis Leiva Pons, celebrated the first 25 years of our society’s life together with some of the greatest international personalities in our field (Dr. Gregg Stone, Dr. Martin Leon and Dr. Patrick Serruys) and former SOLACI

Remodelado miocárdico reverso luego del reemplazo valvular

Loss in Life Expectancy after Surgical Aortic Valve Replacement

This study found after surgical aortic valve replacement (SAVR) patients had shorter life expectancy, compared against the general population. This loss in life expectancy was significant, especially in young patients. These results provide essential information to advice patients before and after SAVR. This is an observational national cohort study to assess long term relative survival

Implicancias clínicas de las nuevas guías de Hipertensión Arterial

Clinical Implications of the New Hypertension Guidelines

Hypertension is the first modifiable risk factor affecting morbidity and mortality in nearly half of the adults in the US. The new ACC/AHA guidelines have issued new standards for the detection assessment and management of high blood pressure. The major change compared against their prior version was stage 1 hypertension definition, defined as systolic blood

Infarto agudo de miocardio y lesiones de múltiples niveles

New Promising Alternatives for Mitral Regurgitation

PASCAL transcatheter valve repair system for mitral regurgitation has shown feasibility and safety to treat patients with grade 3+ or 4+, regardless etiology. Regurgitation grade was significantly reduced, and this was accompanied by clinical improvement in functional class, exercise capacity and quality of life. This study soon to be published in J Am Coll Cardiol

Resultados a 5 años del cierre de orejuela

5-Year Experience of Appendage Closure: More Evidence that Does Not Translate into Clinical Practice

The use of percutaneous left appendage closure increased 3.6-fold from 2011 to 2015, but this volume increase did not entail a significant uptrend of in-hospital events in this “real-world” population in Germany. However, can Germany be considered a real-world setting for Latin America? This question is warranted by the fact that there is no apparent

El alta en el mismo día luego de una angioplastia coronaria es cada vez más popular pero todavía no es regla

Next-Day Discharge after TAVR: Equally Safe for All Prosthesis?

Yet scarce, there is evidence supporting next-day discharge (NDD) after TAVR is safe when patients receiving balloon expandable valves meet certain conditions. This had not yet been shown for self-expandable valves. This study looks into NDD after TAVR by femoral access with self-expandable valves.  The authors retrospectively compared all consecutive patients undergoing elective minimalist TAVR

Lo más leído de Junio en cardiología intervencionista

The Most Read Articles in Interventional Cardiology in SOLACI

1- What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg The decision to be made with a treatment-free patient with systolic blood pressure over 160 mmHg or diastolic blood pressure over 100 mmHg is an easy one. All guidelines agree: treatment should be started immediately alongside lifestyle changes. Read also HERE 2- Low-Risk